Riskpilot← Back to searchSign inGet full accessNordic Labtech AB
ABActiveOrg 5560508136Äskatorpsvägen 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 194724 employees
Revenue 2024
SEK 68,8M
+5% vs 2023
EBITDA margin
5.6%
+195% vs 2023
Equity ratio
10.4%
Financial strength
Net profit 2024
SEK 461K
+110% vs 2023
| Revenue | SEK 68,8M | +5% |
| EBITDA | SEK 3,8M | +195% |
| Net profit | SEK 461K | +110% |
| Total assets | SEK 51,2M | +24% |
| Equity | SEK 5,3M | +9% |
| Employees | 24 | — |
Legal name
Nordic Labtech AB
Org number
5560508136
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 oktober 1947
Share capital
SEK 100 000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska vara en ledande tillverkare och leverantör av LAF-utrustning och skyddsventilation på den europeiska marknaden. Utöver detta skall vi vara en komplett leverantör av laboratorieinredning på den skandinaviska marknaden.
Address
Äskatorpsvägen 4
Phone
+4630035850
Email
rol@nordiclabtech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 42 323 | 40 597 | 64 973 | 18 223 | 72 571 | 65 579 | 68 766 |
| Staff expenses | — | — | — | — | — | — | — | −16 871 | −20 340 | −16 487 |
| EBITDA | 1 929 | 2 753 | 2 992 | 696 | 1 202 | 10 479 | 629 | 4 805 | −4 023 | 3 828 |
| Depreciation & amort. | −36 | −104 | −169 | −370 | −682 | −1 099 | −420 | −1 449 | −1 846 | −2 199 |
| EBIT | 1 893 | 2 649 | 2 823 | 326 | 520 | 9 380 | 209 | 3 357 | −5 869 | 1 629 |
| Net financials | −34 | −19 | −32 | −49 | −256 | −26 | −99 | −441 | −913 | −1 508 |
| Profit before tax | 1 359 | 1 971 | 2 041 | 277 | 264 | 8 521 | 110 | 453 | −4 757 | 451 |
| Tax | −304 | −442 | −508 | −90 | −76 | −1 836 | −35 | −137 | — | 10 |
| Net profit | 1 055 | 1 529 | 1 533 | 187 | 188 | 6 685 | 75 | 316 | −4 757 | 461 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 286 | 11 865 | 16 146 | 17 347 | 21 821 | 27 023 | 34 854 | 41 821 | 41 182 | 51 194 |
| Equity | 1 138 | 1 629 | 3 162 | 2 349 | 2 537 | 9 222 | 9 297 | 9 613 | 4 856 | 5 317 |
| Long-term debt | 0 | 0 | 0 | 3 586 | 1 691 | 0 | 7 904 | 9 522 | 26 491 | 25 448 |
| Short-term debt | 5 148 | 9 276 | 11 574 | 10 002 | 14 842 | 15 558 | 15 411 | 20 740 | 9 734 | 20 428 |
| Total debt | 5 148 | 9 276 | 11 574 | 13 588 | 16 533 | 15 558 | 23 315 | 30 262 | 36 226 | 45 877 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20162024
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20162024
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20162024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20162024
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20162024
Debt / equity
8.63×
This company
0.62×
Market median
-1292% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-09-01 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EH Chief Auditor | Chief Auditor | 2022 | — | — |
JV Chief Auditor | Chief Auditor | 2022 | — | — |
JC Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LK Chief Auditor | Chief Auditor | 2020 | — | — |
ZM Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — | |
| Chairman | 2021 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Screen Capital 4 AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BS Förvaltning AB
Nordic Labtech AB Board members of Nordic Labtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ewelynne Helen Elonsson | Chief Auditor | 0 companies |
| Jarl Vidar Thomas Widarsson | Chief Auditor | 0 companies |
| Jan Christian Janson-Wiklund | Chief Executive Officer | 0 companies |
| Lennart Kristoffer Fristedt | Chief Auditor | 0 companies |
| Zlatan Mitrovic | Chief Auditor | 0 companies |
| Sven Arne Karlsson | Chairman | 0 companies |
| Bengt Anders Längnäs | Chairman | 0 companies |
| Anneli Ingmari Christina Sjölund | Deputy Board Member | 0 companies |
| Wilhelm Håkan Foss | Board of Directors | 0 companies |
| Bo Fredrik Skanselid | Board of Directors | 0 companies |
| Niclas Anders Ingemar Nordin | Chairman | 0 companies |